These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 23590130)
21. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Eloy C; Santos J; Soares P; Sobrinho-Simões M Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104 [TBL] [Abstract][Full Text] [Related]
22. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468 [TBL] [Abstract][Full Text] [Related]
23. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights. Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany. Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986 [TBL] [Abstract][Full Text] [Related]
25. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography. Chai YJ; Kim SJ; Kim SC; Koo do H; Min HS; Lee KE; Kim JH; Youn YK Clin Endocrinol (Oxf); 2014 Sep; 81(3):432-9. PubMed ID: 24548081 [TBL] [Abstract][Full Text] [Related]
26. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations. Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855 [TBL] [Abstract][Full Text] [Related]
27. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines. Kurian EM; Dawlett M; Wang J; Gong Y; Guo M Diagn Cytopathol; 2012 May; 40 Suppl 1():E69-73. PubMed ID: 21538966 [TBL] [Abstract][Full Text] [Related]
28. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715 [TBL] [Abstract][Full Text] [Related]
29. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma. Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500 [TBL] [Abstract][Full Text] [Related]
30. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis. Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337 [TBL] [Abstract][Full Text] [Related]
31. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts. Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852 [TBL] [Abstract][Full Text] [Related]
32. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma. Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583 [TBL] [Abstract][Full Text] [Related]
33. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC. Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294 [TBL] [Abstract][Full Text] [Related]
34. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615 [TBL] [Abstract][Full Text] [Related]
35. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens. Meng Z; Lu J; Wu H; Zhao Y; Luo Y; Gao J; Zhu Q; Jiang Y; Li W; Liang Z Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026 [TBL] [Abstract][Full Text] [Related]
36. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker. Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of Kim H; Kim BH; Kim YK; Kim JM; Oh SY; Kim EH; Lee MJ; Kim JH; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ J Korean Med Sci; 2018 Jul; 33(27):e75. PubMed ID: 29962924 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of FNAC combined with BRAF Fu J; Yin X; Wang X; Xiao S; Wu X; Duan C; Yu W; Zhang G Front Endocrinol (Lausanne); 2024; 15():1366724. PubMed ID: 38818506 [TBL] [Abstract][Full Text] [Related]
40. VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases. Lee SR; Yim H; Han JH; Lee KB; Lee J; Soh EY; Kim DJ; Chung YS; Jeong SY; Sheen SS; Park SH; Kim JH Am J Clin Pathol; 2015 Mar; 143(3):437-44. PubMed ID: 25696803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]